Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04670640 · ClinicalTrials.gov registry record · NA
Mechanistic Interventions and Neuroscience of Dissociation
A NA study of Dissociation, sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 350
- Enrollment target
- 2
- Study locations
NCT04670640: Recruiting NA study of Dissociation, sponsored by Emory University.
NCT04670640 is a NA study of Dissociation that is actively recruiting participants, run by Emory University. The registered enrollment target is 350 participants, above the 56-participant average among 4 other Dissociation trials with a reported enrollment target (525% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04670640, a NA study of Dissociation, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to test the neurophysiological mechanisms of an intervention to reduce symptoms of dissociation in traumatized people. The intervention will be tested in dissociative traumatized people at two sites: Emory University and University of Pittsburgh. The researchers are interested in whether neural networks associated with attentional control and interoceptive awareness can be enhanced in this population. The researchers propose to evaluate whether different body-focused and non-body focused interventions can change these mechanisms.
Primary Outcome
The CAPS is a 30-item structured interview that can be used to make current and lifetime diagnosis of post traumatic stress disorder (PTSD) as well as assess PTSD symptoms over the past week. Questions also examine the onset and duration of symptoms, subjective distress, impact of symptoms on social and occupational functioning, improvement in symptoms since a previous CAPS administration, overall response validity, overall PTSD severity, and specifications for the dissociative subtype (deperson
Conditions Studied
Interventions
- DEVICE Vibration
- BEHAVIORAL Breath Focus
- BEHAVIORAL No Distractions
Study Locations (2)
Georgia
- Grady Hospital - Atlanta
Pennsylvania
- Western Psychiatric Institute and Clinic - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2021-09-18 |
| Est. Completion | 2026-01-31 |
| Phase | NA |
What NCT04670640 shows while recruiting
NCT04670640 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, above the 56-participant average among 4 other Dissociation trials with a reported enrollment target (525% higher).
The record links to 1 condition, with Dissociation appearing as the primary indexed condition, and to 3 interventions - of which Vibration is the first listed.
NCT04670640 reports a single indexed study location in Georgia, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04670640 about?
NCT04670640 is a clinical study titled "Mechanistic Interventions and Neuroscience of Dissociation". The purpose of this study is to test the neurophysiological mechanisms of an intervention to reduce symptoms of dissociation in traumatized people. The intervention will be tested in dissociative traumatized people at two sites: Emory University and University of Pittsburgh. The researchers are inte...
What is the current status of trial NCT04670640?
This trial is currently recruiting. It is a NA study. The enrollment target is 350 participants. The study started on 2021-09-18. Estimated completion is 2026-01-31.
What conditions does trial NCT04670640 study?
This clinical trial studies the following conditions: Dissociation.
What interventions are being tested in trial NCT04670640?
The interventions under investigation include: Vibration (DEVICE), Breath Focus (BEHAVIORAL), No Distractions (BEHAVIORAL).
Who is sponsoring clinical trial NCT04670640?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04670640 being conducted?
This trial has 2 study locations across Georgia, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dissociation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
An Intervention to Enhance Well-Being in Trauma Exposed New Mothers
ACTIVE NOT RECRUITING · NA
-
An Adjunctive Neurofeedback Training Program to Enhance Wellness Among Trauma-Exposed Postpartum Mothers
ACTIVE NOT RECRUITING · NA
-
Low-Dose Ketamine Infusion During Burn Wound Care
RECRUITING · Phase 4
-
Body-Oriented Therapy for Sexual Abuse Recovery
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI